Weller M - Search Results

1

DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.

Witt H, Gramatzki D, Hentschel B, Pajtler KW, Felsberg J, Schackert G, Löffler M, Capper D, Sahm F, Sill M, von Deimling A, Kool M, Herrlinger U, Westphal M, Pietsch T, Reifenberger G, Pfister SM, Tonn JC, Weller M; German Glioma Network. Witt H, et al. Among authors: weller m. Neuro Oncol. 2018 Nov 12;20(12):1616-1624. doi: 10.1093/neuonc/noy118. Neuro Oncol. 2018. PMID: 30053291 Free PMC article.

2

CD95 ligand-induced apoptosis of human medulloblastoma cells.

Weller M, Schuster M, Pietsch T, Schabet M. Weller M, et al. Cancer Lett. 1998 Jun 19;128(2):121-6. doi: 10.1016/s0304-3835(98)00019-6. Cancer Lett. 1998. PMID: 9683272

3

New aspects of immunotherapy of leptomeningeal metastasis.

Herrlinger U, Weller M, Schabet M. Herrlinger U, et al. Among authors: weller m. J Neurooncol. 1998 Jun-Jul;38(2-3):233-9. doi: 10.1023/a:1005948722912. J Neurooncol. 1998. PMID: 9696377 Review.

4

BCL-2 promotes migration and invasiveness of human glioma cells.

Wick W, Wagner S, Kerkau S, Dichgans J, Tonn JC, Weller M. Wick W, et al. Among authors: weller m. FEBS Lett. 1998 Dec 4;440(3):419-24. doi: 10.1016/s0014-5793(98)01494-x. FEBS Lett. 1998. PMID: 9872414 Free article.

5

Primary central nervous system lymphoma 1991-1997: outcome and late adverse effects after combined modality treatment.

Herrlinger U, Schabet M, Brugger W, Kortmann RD, Kanz L, Bamberg M, Dichgans J, Weller M. Herrlinger U, et al. Among authors: weller m. Cancer. 2001 Jan 1;91(1):130-5. doi: 10.1002/1097-0142(20010101)91:1<130::aid-cncr17>3.0.co;2-8. Cancer. 2001. PMID: 11148569

6

Treosulfan chemotherapy for recurrent malignant glioma.

Schmidt F, Wick W, Herrlinger U, Dichgans J, Weller M. Schmidt F, et al. Among authors: weller m. J Neurooncol. 2000 Sep;49(3):231-4. doi: 10.1023/a:1006496831144. J Neurooncol. 2000. PMID: 11212902 Clinical Trial.

7

Primary CNS lymphoma in the spinal cord: clinical manifestations may precede MRI detectability.

Herrlinger U, Weller M, Küker W. Herrlinger U, et al. Among authors: weller m. Neuroradiology. 2002 Mar;44(3):239-44. doi: 10.1007/s002340100701. Neuroradiology. 2002. PMID: 11942380

8

First-line therapy with temozolomide induces regression of primary CNS lymphoma.

Herrlinger U, Küker W, Platten M, Dichgans J, Weller M. Herrlinger U, et al. Among authors: weller m. Neurology. 2002 May 28;58(10):1573-4. doi: 10.1212/wnl.58.10.1573. Neurology. 2002. PMID: 12034807 No abstract available.

9

Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets.

Mueller W, Hartmann C, Hoffmann A, Lanksch W, Kiwit J, Tonn J, Veelken J, Schramm J, Weller M, Wiestler OD, Louis DN, von Deimling A. Mueller W, et al. Among authors: weller m. Am J Pathol. 2002 Jul;161(1):313-9. doi: 10.1016/S0002-9440(10)64183-1. Am J Pathol. 2002. PMID: 12107116 Free PMC article.

10

Gliomatosis cerebri: molecular pathology and clinical course.

Herrlinger U, Felsberg J, Küker W, Bornemann A, Plasswilm L, Knobbe CB, Strik H, Wick W, Meyermann R, Dichgans J, Bamberg M, Reifenberger G, Weller M. Herrlinger U, et al. Among authors: weller m. Ann Neurol. 2002 Oct;52(4):390-9. doi: 10.1002/ana.10297. Ann Neurol. 2002. PMID: 12325066

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,695 results

Search Page